Psilocybin clinical trials in Alabama
5 trials with 6 study sites in Alabama, recruiting or not yet recruiting, read from ClinicalTrials.gov on 28 October 2026. The site in Alabama is named under each trial.
- RecruitingEarly phase 1NCT05068791
Psilocybin-facilitated Treatment for Chronic Pain
Fibromyalgia, Primary · University of Alabama at Birmingham · Ages 25 to 65
Birmingham, Alabama, United States
In Alabama: UAB Beacon Tower, Birmingham
- RecruitingPhase 2NCT05452772
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
Tobacco Use Disorder · Johns Hopkins University · Ages 21+
3 sites in United States (Birmingham, Baltimore, New York)
In Alabama: University of Alabama at Birmingham, Birmingham
- RecruitingPhase 3NCT06793397
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder · Cybin IRL Limited · Ages 18 to 85
79 sites in 8 countries
In Alabama: UAB Psychiatry and Behavioral Neurology, Birmingham
- RecruitingPhase 3NCT07226232
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
Major Depression · VA Office of Research and Development · Ages 18 to 75
5 sites in United States
In Alabama: Birmingham VA Medical Center, Birmingham, AL, Birmingham; Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa
- Not yet recruitingPhase 2NCT07774702
Psilocybin for Methamphetamine Use Disorder
Methamphetamine Use Disorder · Peter Hendricks · Ages 18+
Birmingham, Alabama, United States
In Alabama: University of Alabama at Birmingham, Birmingham
How joining a trial works
- Free to take part
- Trials generally cost participants nothing for the study drug and the study visits, and some pay for travel or time. Check what a study covers on its registry page.
- Screened first
- Every study screens volunteers with questionnaires, medical history and often a physical and psychiatric check. Many people who apply are not enrolled.
- Eligibility is strict
- Common exclusions include a personal or family history of psychosis or bipolar disorder, some heart conditions, pregnancy and certain medications, which you may be asked to stop under medical supervision. Never stop a medication on your own to qualify.
- You may get a placebo
- Many trials compare psilocybin with a placebo or a low dose, and you may not be told which you had until the study ends.
- Contact the study team through the registry
- Each registry record lists the study contacts and sites. We do not republish personal emails or phone numbers; use the link on each trial page.
- Not medical advice
- This is a list of registry records, not a recommendation. Talk to your doctor before applying. Disclaimer · Safety and medications
Source: ClinicalTrials.gov API v2, U.S. National Library of Medicine, read 28 October 2026. Filter: overall status RECRUITING or NOT_YET_RECRUITING; an intervention named psilocybin, psilocin, COMP360 or CYB003. Refreshed weekly; a study's own registry page is always the current record.